Is COR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.

COR (Cencora, Inc.) Stock Analysis - Financials

Cencora, Inc. (COR) is a publicly traded Healthcare sector company. As of August 25, 2026, COR trades at $323.92 with a market cap of $60.69B and a P/E ratio of 156.63. COR moved +0.05% today. Year to date, COR is -4.14%; over the trailing twelve months it is +10.65%. Its 52-week range spans $223.92 to $377.54. Analyst consensus is strong buy with an average price target of $369.18. Rallies surfaces COR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are COR's key financials?

COR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COR recently traded at $323.92. Market cap is $60.69B. P/E ratio is 156.63. Revenue is $638.56M.

COR Key Metrics

Key financial metrics for COR
Metric	Value
Price	$323.92
Market Cap	$60.69B
P/E Ratio	156.63
EPS	$2.06
Dividend Yield	0.60%
52-Week High	$377.54
52-Week Low	$223.92
Volume	69
Avg Volume	0
Revenue (TTM)	$638.56M
Net Income	$99.92M
Gross Margin	0.00%

COR Analyst Consensus

12 analysts cover COR: 0 strong buy, 9 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $369.18.

Common questions about COR

What are COR's key financials?: COR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. COR recently traded at $323.92. Market cap is $60.69B. P/E ratio is 156.63. Revenue is $638.56M.
Is COR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for COR. It does not provide personalized investment advice.